724 organization(s) found
MATWIN
Maturation & Accelerating Translation With Industry (MATWIN) is the only French open-innovation platform specifically dedicated to oncology. MATWIN, a wholly owned subsidiary of Unicancer group (gathering all the French Comprehensive Cancer Centres) offers since 15 years several actions (expertise, accelerating program, events, etc.) aiming at accelerating the development of innovative projects dedicated to the fight against cancer.
Mayo Clinic
Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world. We're building the future, one where the best possible care is available to everyone — and more people can heal at home. Our relentless research turns into earlier diagnoses and new cures. That's how we inspire hope in those who need it most.
MCRI (Murdoch Children’s Research Institute)
As Australia’s largest child health research centre, we bring together the brightest minds to solve the biggest health issues for children. Our team of more than 1,800+ world-leading researchers works across over 150 common and rare childhood diseases and conditions. Our mission is to improve the health and wellbeing of children everywhere. Many of our researchers are clinicians at The Royal Children’s Hospital in Melbourne, where MCRI is based.
MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is one of the world’s most respected centers devoted exclusively to cancer patient care, research, education and prevention. The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public. We shall be the premier cancer center in the world, based on the excellence of our people, our research-driven patient care and our science. We are Making Cancer History®.
Medicaid Cancer Foundation / Medicaid Radio Diagnostics – Nigeria
Listed among NGO organisations working on cancer advocacy in Nigeria.
Medical & Community Support Organisation Uganda
Civil society organisation working for cancer control and community support in Uganda, listed among cancer-advocacy bodies.
Memorial Sloan Kettering Cancer Center
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.
MENA Hematology League
The MENA Hematology League was announced on January 21st, 2019, and is licensed as a non-profit organization in the United Kingdom (England and Wales), with registration number 11777391, and is based in London (Unit 3, Office A, 1st Floor, 6-7 St Mary at Hill, London, England EC3R 8EE). [ https://find-and-update.company-information.service.gov.uk/company/11777857 ]. The League was founded by Prof. Ahmad Tarawah. To date, 21 Middle East countries have been represented in the league. The MENA Hematology League is managed by a board of directors representing MENA countries. The league has eight offices distributed in the United Kingdom, Saudi Arabia, Egypt and the United Arab Emirates. More than 35,000 members are registered. Three congresses and more than ten forums have been conducted in Saudi Arabia, Egypt, Algeria, Yemen and Qatar. More than 500 research studies have been presented at MENA congresses and published in medical journals.
Menarini
High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These five pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with more than 135 years of history.
Merck
As a vibrant science and technology company, there's nothing small in what we do.
Mestag Therapeutics
Mestag is an immunology company driving first-in-class treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we are rapidly advancing a pipeline of sophisticated agonist antibody programs and exploring our RAFT target discovery platform to identify new targets for the development of new treatments.
Micro CRISPR
Accelerating the synthetic biology revolution, one gene at a time: Micro CRISPR is a new age biotechnology company with an outlier mindset on a quest to improve millions of lives. We strive to lead with our core values and to help spread ideas of sustainability and responsibility whose impact can reach far beyond our own business.
MIN (Melbourne Immunotherapy Network)
The Melbourne Immunotherapy Network (MIN) was launched in 2016 by University of Melbourne Professors Dale Godfrey, Sharon Lewin and Fabienne Mackay at the Doherty Institute, and Professors Joe Trapani and Professor Ricky Johnstone, from The Peter MacCallum Cancer Centre. This network was set-up to harness and combine the immunology and immuno-oncology excellence in the Melbourne area by bringing together researchers across Melbourne to present what’s new in the Immunotherapy related field.
Moderna
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Modern Cancer Hospital (Guangzhou)
A private / possibly international-serving cancer hospital — represents non-state/private sector involvement in cancer care and potentially alternative treatment routes (esp. for foreign or affluent patients). (Less publicly documented)